Casopitant: a novel NK1-receptor antagonist in the prevention of chemotherapy-induced nausea and vomiting
Christina Ruhlmann, Jørn HerrstedtOdense University Hospital, Department of Oncology, Odense, DenmarkAbstract: Chemotherapy-induced nausea and vomiting (CINV) are among the most feared and distressing symptoms experienced by patients with cancer. The knowledge of the pathogenesis and...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-05-01
|
Series: | Therapeutics and Clinical Risk Management |
Online Access: | http://www.dovepress.com/casopitant-a-novel-nk1-receptor-antagonist-in-the-prevention-of-chemot-a3117 |